Form 4 for CYTK CYTOKINETICS INC
Accepted 2021-10-14 00:00:00 ET · period of report 2021-10-14 · accession 0001061983-21-000235 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-14 | 2021-10-14 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $37.73 | -2,000 | 150.9K | -1% | -$75.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-14 | S | D | 2,000 | $37.73 | 150,878 | D | — | — | (F2) Includes 2,000 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). |